Amgen, Inc. (AMGN) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Amgen (AMGN) Q1 'Disappointing' - Nomura
April 23, 2014 7:43 AM EDTNomura Securities analyst M. Ian Somaiya reiterated a Neutral rating on Amgen (NASDAQ: AMGN) and trimmed his price target from $130 to $129 following 'Disappointing' Q1 results.
Somaiya said, "We are lowering estimates and target price to $129 from $130 following a disappointing 1Q14 earnings that... More
